Vertex Pharmaceuticals Inc. / MA (VRTX) on GreekSoup https://greeksoup.ai/stocks/us/vrtx/ Every dated entry in the public record on Vertex Pharmaceuticals Inc. / MA: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 23 Sep 2026 00:00:00 +0000 Vertex Pharmaceuticals Inc. / MA: David J. Taylor (OH02) disclosed a sale, $1,001 - $15,000, traded 26 August 2026https://greeksoup.ai/stocks/us/vrtx/congress/us:VRTX:congress:2026-09-05:31f4c4359fSat, 05 Sep 2026 00:00:00 +0000House tradeHouse trade. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA filed 8-K: officer or director changehttps://greeksoup.ai/stocks/us/vrtx/filings/us:VRTX:filing:2026-09-01:e75a4029d6Tue, 01 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA: short interest 4,659,749 shares at the 31 August 2026 settlement, 4.51 days to coverhttps://greeksoup.ai/stocks/us/vrtx/short-interest/us:VRTX:short-interest:2026-08-31:085cfdcb17Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA: Form 144, Bruce I. Sachs plans to sell 1,210 shares worth $662,536 around 27 August 2026https://greeksoup.ai/stocks/us/vrtx/planned-sales/us:VRTX:planned-sale:2026-08-27:a1336190d8Thu, 27 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA: short interest 4,146,973 shares at the 14 August 2026 settlement, 3.09 days to coverhttps://greeksoup.ai/stocks/us/vrtx/short-interest/us:VRTX:short-interest:2026-08-14:a9d0ecb462Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA Q2 FY2026 results: revenue $3.3 billion, net income $1.1 billionhttps://greeksoup.ai/stocks/us/vrtx/results/fy2026-q2/us:VRTX:result:2026-08-04:a9bbcc45c0Tue, 04 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/vrtx/filings/us:VRTX:filing:2026-08-04:8d1971f458Tue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/vrtx/filings/us:VRTX:filing:2026-08-03:ec0ff1a2c6Mon, 03 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA: short interest 3,942,936 shares at the 31 July 2026 settlement, 2.99 days to coverhttps://greeksoup.ai/stocks/us/vrtx/short-interest/us:VRTX:short-interest:2026-07-31:a934c10719Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA: short interest 4,986,691 shares at the 15 July 2026 settlement, 3.10 days to coverhttps://greeksoup.ai/stocks/us/vrtx/short-interest/us:VRTX:short-interest:2026-07-15:d969a1802bWed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA filed 8-K: material agreement, regulation fd disclosure, other eventshttps://greeksoup.ai/stocks/us/vrtx/filings/us:VRTX:filing:2026-07-07:d0a8942449Tue, 07 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA: Tatsis Ourania (EVP, Chief Reg. & Quality Off.) sold 1,500 shares at $524.99 on 2 July 2026, $787,485https://greeksoup.ai/stocks/us/vrtx/insiders/us:VRTX:insider:2026-07-07:0b3569ab9eTue, 07 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA: Mckechnie Duncan (EVP, Chief Commercial Officer) sold 1,541 shares at $519.00 on 2 July 2026, $799,779https://greeksoup.ai/stocks/us/vrtx/insiders/us:VRTX:insider:2026-07-07:518dc31a3fTue, 07 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA: Liu Joy (EVP and Chief Legal Officer) sold 828 shares at $502.71 on 1 July 2026, $416,244https://greeksoup.ai/stocks/us/vrtx/insiders/us:VRTX:insider:2026-07-06:2c1ff1fd16Mon, 06 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA: Form 144, Tatsis Ourania plans to sell 1,500 shares worth $787,485 around 2 July 2026https://greeksoup.ai/stocks/us/vrtx/planned-sales/us:VRTX:planned-sale:2026-07-02:ebb1fee2d8Thu, 02 Jul 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA: Form 144, McKechnie Duncan plans to sell 1,541 shares worth $799,779 around 2 July 2026https://greeksoup.ai/stocks/us/vrtx/planned-sales/us:VRTX:planned-sale:2026-07-02:8c3b532716Thu, 02 Jul 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA: Form 144, Liu Joy plans to sell 828 shares worth $416,244 around 1 July 2026https://greeksoup.ai/stocks/us/vrtx/planned-sales/us:VRTX:planned-sale:2026-07-01:b0f3cdac15Wed, 01 Jul 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA: Bozic Carmen (EVP and CMO) sold 596 shares at $482.50 on 26 June 2026, $287,570https://greeksoup.ai/stocks/us/vrtx/insiders/us:VRTX:insider:2026-06-30:e5336b8753Tue, 30 Jun 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA: short interest 4,938,472 shares at the 30 June 2026 settlement, 2.01 days to coverhttps://greeksoup.ai/stocks/us/vrtx/short-interest/us:VRTX:short-interest:2026-06-30:f9cda94e9bTue, 30 Jun 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Vertex Pharmaceuticals Inc. / MA: Form 144, Bozic Carmen plans to sell 596 shares worth $287,570 around 26 June 2026https://greeksoup.ai/stocks/us/vrtx/planned-sales/us:VRTX:planned-sale:2026-06-26:1d75af7a68Fri, 26 Jun 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]>